Bristol-Myers gets EU approval for diabetes drug - The Associated Press
dBTechnoBristol-Myers gets EU approval for diabetes drugThe Associated PressNEW YORK %26mdash; Drugmaker Bristol-Myers Squibb Co. says its new diabetes drugs, Onglyza, has been approved for sale in the European Union's 27 countries. ...AstraZeneca: Onglyza EU Marketing AuthorisationWall Street JournalBoehringer Sees 'Uphill Battle' With Merck, Astra in DiabetesBloombergAstra says Onglyza gets EC green lightShareCastall 125 news articles��
Blog Content
No comments:
Post a Comment